Osr Health Inc (OSRH)

Aug 21, 2026

OSR Health: Preparing Our Appeal, Advancing Our Catalysts, Continuing Our Mission - ACCESS Newswire

Aug 21, 2026

Aug 20, 2026

OSR (OSRH) Quarter in Focus: EPS Falls Short of Its Estimate in the Latest Reading; Market Move: Shares Move 20.96% LowerEnergy Earnings Report - vinanet.vn

Aug 20, 2026

Aug 20, 2026

OSR Health Faces Nasdaq Delisting Risk Due to Non-Compliance - Intellectia AI

Aug 20, 2026

Aug 19, 2026

Form 8K OSR Holdings Inc For: 19 August By Investing.com - Investing.com Australia

Aug 19, 2026

Aug 19, 2026

OSR Holdings Faces Nasdaq Delisting, Plans Appeal - TipRanks

Aug 19, 2026

Aug 19, 2026

OSR Health Received Notice of Delisting - TradingView

Aug 19, 2026

Aug 19, 2026

Nasdaq to delist OSR Health after bid price compliance failure - Investing.com

Aug 19, 2026

Aug 19, 2026

OSR Health Receives Nasdaq Staff Delisting Determination and Intends to Request Hearings Panel Appeal - Caledonian Record

Aug 19, 2026

Aug 19, 2026

OSR Health (OSRH) Stock Forecast & Analyst Ratings - Moomoo

Aug 19, 2026

Aug 19, 2026

OSR Health(OSRH) Stock Options Chain | Quotes & News - Moomoo

Aug 19, 2026

Aug 19, 2026

OSR Health Sees Global Shareholder Momentum at Critical Inflection Point - ACCESS Newswire

Aug 19, 2026

Aug 19, 2026

$OSR Health (OSRH.US)$ Why hiding this details - Moomoo

Aug 19, 2026

Aug 18, 2026

These stocks are the most active in today's session - ChartMill

Aug 18, 2026

Aug 18, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Aug 18, 2026

Aug 17, 2026

Why OSR Health (OSRH) Stock Is Up Today - Quiver Quantitative

Aug 17, 2026

Aug 17, 2026

VivoSim Labs (NASDAQ: VIVS) Among IGC, OSRH, IVF as FDA-Backed Human-Based Testing Gains Momentum - Barchart.com

Aug 17, 2026

Aug 17, 2026

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Aug 17, 2026

Aug 17, 2026

$OSR Health (OSRH.US)$ quick one! i think its probably going up more but im done for the night! GL everyone 🫰🏽 - Moomoo

Aug 17, 2026

Aug 15, 2026

OSRH Q4 2025 Earnings: Loss Widens 56.86% Above Forecast, Yet Shares Climb 11.66%Forward Guidance Trends - vinanet.vn

Aug 15, 2026

Aug 14, 2026

OSR Health, Inc. Q2 2026: Revenue $316K, Net loss $(849K), EPS $(0.02) — 10-Q Summary - TradingView

Aug 14, 2026

Aug 14, 2026

OSR Health (OSRH) cuts losses but faces sharp revenue drop and tight cash - Stock Titan

Aug 14, 2026

Aug 14, 2026

OSRH Stock Price and Chart — NASDAQ:OSRH - TradingView

Aug 14, 2026

Aug 12, 2026

OSR Health Issues Clarification Regarding Prior Nasdaq Communication and Shareholder Loyalty CVR Program - ACCESS Newswire

Aug 12, 2026

Aug 11, 2026

OSR Health faces Nasdaq delisting deadline, cites licensing talks By Investing.com - Investing.com Australia

Aug 11, 2026

Aug 11, 2026

OSR Health faces Nasdaq delisting deadline, cites licensing talks - Investing.com

Aug 11, 2026

Aug 11, 2026

OSR Health CEO Reaffirms Confidence and Highlights Subsidiary Business Development - New Castle News

Aug 11, 2026

Aug 11, 2026

OSR Health clarifies Nasdaq has not approved shareholder loyalty CVR program - Bitget

Aug 11, 2026

Aug 10, 2026

Form 8K OSR Holdings Inc For: 10 August By Investing.com - Investing.com Nigeria

Aug 10, 2026

Aug 10, 2026

OSR Health re-elects board and approves key proposals at annual meeting - Investing.com

Aug 10, 2026

Aug 08, 2026

OSR Health, Inc. (OSRHW) Stock Price, News, Quote & History - Yahoo! Finance Canada

Aug 08, 2026

Aug 08, 2026

Form 8K OSR Holdings Inc For: 7 August By Investing.com - Investing.com India

Aug 08, 2026

Aug 07, 2026

OSR Holdings Clarifies Nasdaq Stance on CVR Program - TipRanks

Aug 07, 2026

Aug 07, 2026

OSR Health clarifies Nasdaq did not endorse CVR program; record date remains Aug 14 - TradingView

Aug 07, 2026

Aug 07, 2026

News by ACCESS Newswire on TradingView, 2026-08-07 - TradingView

Aug 07, 2026

Aug 03, 2026

OSR (OSRH) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - marketbeat.com

Aug 03, 2026

Aug 03, 2026

OSR Health subsidiary completes glioblastoma vaccine analysis By Investing.com - Investing.com Australia

Aug 03, 2026

Aug 03, 2026

OSR Health subsidiary completes glioblastoma vaccine analysis - Investing.com

Aug 03, 2026

Aug 03, 2026

Vaximm AG, an OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its VEGFR-2-Targeted Cancer Vaccine Platform - New Castle News

Aug 03, 2026

Aug 03, 2026

Vaximm Announces VXM01 Glioblastoma Data Publication Plans - ACCESS Newswire

Aug 03, 2026

Jul 31, 2026

OSR Health says Nasdaq won’t apply price adjustment for loyalty CVR distribution - TradingView

Jul 31, 2026

Jul 31, 2026

OSR Health Secures Nasdaq Communication: Loyalty CVR Program Will Not Trigger a Price Adjustment - The Joplin Globe

Jul 31, 2026

Jul 29, 2026

OSR Health Inc (BLACU:UR): Stock Price, Quote and News - BNN Bloomberg

Jul 29, 2026

Jul 28, 2026

OSR Holdings Inc (OSRH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 28, 2026

Jul 27, 2026

OSR Holdings Inc (OSRH) Institutional Confidence - TradingKey

Jul 27, 2026

Jul 27, 2026

OSR Holdings Inc (OSRH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 27, 2026

Jul 27, 2026

OSRH|OSR Holdings Inc|Price:0.467|Chg%:+0.021 - TradingKey

Jul 27, 2026

Jul 26, 2026

OSR Holdings Inc (OSRH) Balance Sheet - TradingKey

Jul 26, 2026

Jul 25, 2026

OSR Health, Inc. Revenue Breakdown – NASDAQ:OSRH - TradingView

Jul 25, 2026

Jul 25, 2026

OSRH|OSR Holdings Inc|Price:0.424|Chg%:-0.166 - TradingKey

Jul 25, 2026